← Back to headlines
Ovid Therapeutics advances OV329 epilepsy drug, secures $60M financing
18 Mar, 10:35 — 18 Mar, 10:35
Sources
Showing 1 of 1 sources
Related Stories
Actress Busy Philipps Reveals Diagnosis and Recovery from Rare Brain Tumor
15m ago
Closing Arguments Approach in Murder Trial of Mother Accused of Killing Three Children
32m ago
New Zealand’s Starship Hospital Defers Non-Urgent Cases Amid Pediatric Flu Surge
37m ago
EU Approves Revolutionary Pancreatic Cancer Treatment Improving Survival Rates
46m ago